Home › Funds › TLS Advisors LLC › XENE

TLS Advisors LLC position in XENE

XENON PHARMACEUTICALS INC · Health Care

TLS Advisors LLC reported holding 30,956 shares of XENE (XENON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 5.49% of its reported portfolio and ranking #6 among its reported holdings. TLS Advisors LLC has disclosed XENE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)30.96K sh
Reported value held$1.87M
Portfolio Weight5.49%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TLS Advisors LLC's XENE position evolved

TLS Advisors LLC first disclosed a stake in XENE in Q3 2023 at 32,956 shares (US$1.1M). The position peaked in Q2 2026 at 30,956 shares, worth US$1.9M. Across 12 filings, TLS Advisors LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 30,956 shares valued at US$1.9M. Notable position changes include a 43% trim in Q4 2025 (shares rose 30% over the following quarter), a 64% increase in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.96K $1.13M New
Q4 2023 32.96K $1.52M Hold
Q1 2024 32.96K $1.42M Hold
Q2 2024 32.96K $1.28M Hold
Q3 2024 32.96K $1.30M Hold
Q4 2024 32.96K $1.29M Hold
Q1 2025 32.96K $1.11M Hold
Q2 2025 32.96K $1.03M Hold
Q3 2025 32.96K $1.38M Hold
Q4 2025 18.86K $307.00K Reduce
Q1 2026 30.96K $1.80M Add
Q2 2026 30.96K $1.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XENE and 13F data

XENE (XENON PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in XENE — the largest reported positions include Avoro Capital Advisors LLC (US$348.7M), Polar Capital Holdings Plc (US$275.9M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$266.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XENE

All XENE fund holders →

FAQ

How long has TLS Advisors LLC held XENE?

TLS Advisors LLC has disclosed XENE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TLS Advisors LLC's current position in XENE?

As of Q2 2026, TLS Advisors LLC holds 30.96K shares of XENE (XENON PHARMACEUTICALS INC), valued at $1.87M, representing 5.49% of its reported portfolio and ranking #6.

Has TLS Advisors LLC been buying or selling XENE?

In the latest 13F filing (Q2 2026), TLS Advisors LLC held unchanged its position in XENE. The position peaked in Q2 2026 at 30.96K shares.

Which other funds hold XENE?

Other major institutional holders of XENE include Avoro Capital Advisors LLC, Polar Capital Holdings Plc, DRIEHAUS CAPITAL MANAGEMENT LLC, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.